• LAST PRICE
    1.1700
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    1.0500/ 3
  • Ask / Lots
    1.3100/ 1
  • Open / Previous Close
    0.0000 / 1.1700
  • Day Range
    ---
  • 52 Week Range
    Low 1.1000
    High 10.8700
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 1.2
TimeVolumeCNTX
09:32 ET131111.22
09:34 ET24001.2499
09:36 ET46001.22
09:39 ET1001.2273
09:41 ET11001.2092
09:43 ET1001.2
09:45 ET2001.21
09:48 ET5441.2029
09:50 ET1001.2
09:54 ET1001.22
09:56 ET1001.2
09:57 ET10001.23
09:59 ET10001.2
10:03 ET1001.2
10:08 ET1141.23
10:10 ET1001.21
10:12 ET1001.21
10:17 ET1001.21
10:19 ET1001.2299
10:21 ET1001.2127
10:26 ET1001.21
10:32 ET4331.2109
10:33 ET1001.21
10:39 ET1001.21
10:48 ET1001.21
10:57 ET2001.21
11:02 ET17121.2001
11:06 ET12601.215
11:08 ET1001.2075
11:13 ET4001.215
11:18 ET1001.2075
11:22 ET4001.215
11:24 ET1001.21
11:27 ET1001.2
11:36 ET2001.23
11:38 ET2001.22
11:42 ET2001.22
11:44 ET2001.22
11:47 ET4001.201
11:49 ET2001.22
11:54 ET2001.22
11:56 ET2001.22
12:00 ET2001.22
12:02 ET2001.215
12:05 ET2001.22
12:09 ET1001.215
12:12 ET2001.22
12:14 ET13811.2159
12:20 ET1001.215
12:21 ET3001.21
12:25 ET1001.2125
12:34 ET2001.215
12:36 ET3001.22
12:38 ET11501.215
12:48 ET1001.215
12:52 ET2001.22
12:54 ET2001.22
12:57 ET2001.22
12:59 ET2001.22
01:03 ET2001.22
01:06 ET2001.22
01:10 ET2001.22
01:12 ET6001.215
01:21 ET2001.22
01:24 ET7001.215
01:28 ET1001.22
01:30 ET4001.2181
01:32 ET1001.21
01:35 ET13001.215
01:39 ET6001.215
01:46 ET18001.215
01:50 ET1861.2182
01:51 ET1001.21
02:02 ET4001.21
02:06 ET16081.21
02:08 ET1001.21
02:09 ET2341.2048
02:11 ET1001.2
02:15 ET44061.2
02:20 ET1301.1942
02:22 ET2981.195
02:24 ET1001.19
02:31 ET51321.19
02:38 ET2001.1725
02:40 ET13001.18
02:42 ET2501.1744
02:44 ET4351.18
02:47 ET8001.1884
02:49 ET1001.1895
02:54 ET5001.19
02:56 ET3001.1899
02:58 ET3001.1861
03:00 ET2001.1863
03:02 ET1001.18
03:09 ET1001.18
03:16 ET14001.181
03:20 ET1001.18
03:25 ET10001.19
03:27 ET1001.185
03:34 ET1001.19
03:36 ET1001.19
03:38 ET4001.19
03:39 ET1001.19
03:41 ET12001.19
03:43 ET1001.19
03:45 ET9001.19
03:48 ET103221.18
03:54 ET3001.18
03:56 ET3001.18
03:57 ET6501.18
03:59 ET7001.17
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesCNTX
Context Therapeutics Inc
19.2M
-1.5x
---
United StatesNDRA
ENDRA Life Sciences Inc
19.6M
-1.2x
---
United StatesITRM
Iterum Therapeutics PLC
20.1M
-1.8x
---
United StatesINTI
Inhibitor Therapeutics Inc
17.9M
-35.4x
---
United StatesINDP
Indaptus Therapeutics Inc
19.2M
-1.1x
---
United StatesONCS
OncoSec Medical Inc
19.7M
-0.5x
---
As of 2022-09-28

Company Information

Context Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on improving the lives of women living with cancer. The Company is focused on developing small molecule and immunotherapy treatments to transform care for breast and gynecological cancers. Its lead product candidate, onapristone extended release (ONA-XR), is a selective and potent antagonist of the progesterone receptor (PR), a receptor that is activated by the hormone progesterone and that has been linked to resistance to multiple classes of cancer therapeutics, including anti-estrogen therapies. Its ONA-XR consists of three Phase II clinical trials and one Phase 1Ib/II clinical trial in hormone-driven breast, ovarian, and endometrial cancer. Its second program, CLDN6xCD3 bsAb, is an anti-CD3 x anti-Claudin 6 (CLDN6) antigen bispecific monoclonal antibody (bsAbs) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

Contact Information

Headquarters
2001 Market Street, Suite 3915 Unit #15PHILADELPHIA, PA, United States 19103
Phone
267-225-7416
Fax
302-655-5049

Executives

Independent Chairman of the Board
Richard Berman
President, Chief Executive Officer, Director
Martin Lehr
Chief Financial Officer, Treasurer
Jennifer Minai-Azary
Senior Vice President - Operations
Christopher Beck
Senior Vice President - Research and Development
Evan Dick

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$19.2M
Revenue (TTM)
$0.00
Shares Outstanding
16.0M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-0.79
Book Value
$3.02
P/E Ratio
-1.5x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.